Zydus receives Emergency Use approval for ‘Virafin’ in treating moderate COVID-19 infection in adults. A single dose of Virafin shows significant improvement. 91.15% of patients were RT PCR negative by day 7. It reduces hours of supplemental oxygen in the patients.